|
 |
 |
|
 |
|
Triamcinolone Monitoring Parameters, Administration and Chemical Structure
blood glucose: systemic therapy
PFTs
serum potassium: systemic therapy
--------
Oral Administration
All dosage forms: Administer with meals to minimize gastric indigestion or irritation.
Tablets: May be crushed and mixed with food or fluids for patients with difficulty swallowing.
Oral solution: Administer using a calibrated measuring device for accurate measurement of the dose.
Parenteral Administration
Triamcinolone acetonide or hexatonide injections should never be administered intravenously.
Visually inspect parenteral products for particulate matter and discoloration prior to administration whenever solution and container permit.
Intramuscular injection:
Triamcinolone acetonide may be administered by IM injection.
Shake IM suspension well prior to withdrawing into the syringe.
Inject deeply into a well developed muscle. Aspirate prior to injection to avoid injection into a blood vessel. Rotate sites of injection.
Intra-articular, intrasynovial, intrabursal, soft-tissue, intralesional, or sublesional injection:
Triamcinolone acetonide may be administered by intra-articular, intrasynovial, intralesional or soft tissue injection.
Triamcinolone hexacetonide may be administered by intra-articular, intralesional, or sublesional injection.
Administration of triamcinolone via these routes require specialized techniques. Only clinicians familiar with these methods of administration and with management of potential complications should administer triamcinolone by these routes.
Oral Inhalation Administration
NOTE: The Azmacort® inhaler must be primed prior to the first use. After shaking the inhaler well, spray the aerosol 2 times into the air, away from the eyes, to prime.
Once primed, the canister will remain ready for use for 3 days. If the canister is not used for more than 3 days, then the process of priming should be repeated.
Oral inhalation:
Instruct patient on proper inhalation technique (see Patient Information).
Each metered actuation of the Azmacort inhaler delivers 100 mcg/spray of triamcinolone acetonide to the patient when inhaled from the spacer mouthpiece.
To avoid the spread of infection, do not use the inhaler for more than one person.
Nasal Inhalation Administration
Nasal inhalation:
Each metered actuation of the Nasacort® HFA or Nasacort® AQ inhaler delivers 55 mcg/spray to the patient. Each metered actuation of the Tri-Nasal® inhaler delivers 50 mcg/spray.
Instruct patient on proper inhalation technique (see Patient Information). If nasal passages are blocked, administer a decongestant 5 - 10 minutes prior to administration.
To avoid the spread of infection, do not use the inhaler for more than one person.
Topical Administration
Cream or ointment: Using gloved hands, apply a thin film and rub gently into the cleansed, slightly moist affected area.
Aerosol: Spray an area about the size of the patient’s hand for about 2 seconds at a distance of approximately 7.5 - 15 cm.
--------
Chemical Structure For: Triamcinolone
[ Last revised: 5/18/2004 3:58:00 PM ]
Related entries
Syndicate
|
|
|
